Parkinsonism and elevated lactic acid with sertraline [1]

Canadian Journal of Psychiatry

Volumn 50, Issue 5, 2005, Pages 301-

  Mendhekar, D N ^a   Benuiwal, R P ^a   Puri, V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CLONAZEPAM; DOSULEPIN; PROMETHAZINE; SERTRALINE; TRIHEXYPHENIDYL; LACTIC ACID; SEROTONIN UPTAKE INHIBITOR;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; CONVERSION DISORDER; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LABORATORY TEST; LACTATE BLOOD LEVEL; LETTER; MAJOR DEPRESSION; PARKINSONISM; BASAL GANGLION; BIOSYNTHESIS; BLOOD; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOLOGY; PSYCHOLOGICAL ASPECT;

BASAL GANGLIA; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LACTIC ACID; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PARKINSON DISEASE, SECONDARY; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 22344450139     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370505000516     Document Type: Letter

References (3)

1. Leo RJ. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry1996;57:449-54.
2. Chouinard G, Ross-Chouinard A. Extrapyramidal Symptoms Rating Scale (ESRS). Can J Neurol Sci 1980;7:33-43.
3. Di Mauro S, Schon EA. Mitochondrial DNA and diseases of the nervous system. The spectrum. Neuroscientist 1997;4:53-63.